Literature DB >> 14728616

The cost and cost-effectiveness of malaria vector control by residual insecticide house-spraying in southern Mozambique: a rural and urban analysis.

Lesong Conteh1, Brian L Sharp, Elisebeth Streat, Avertino Barreto, Sundragasen Konar.   

Abstract

OBJECTIVES: To compare two separately funded, but operationally similar, residual household-spraying (RHS) initiatives; one rural and one peri-urban in southern Mozambique.
METHODS: The rural programme is a regional project involving the participation and co-ordination of organizations across three countries in southern Africa and is focussed on control in an area in Mozambique of 7552 km2. The second programme focuses on spraying a peri-urban community within a 10-km radius around MOZAL, an aluminium smelter plant of area 410 km2. An ingredients approach was used to derive unit costs for both the rural and peri-urban spraying programmes using detail retrospective cost data and effectiveness indicators.
RESULTS: The economic cost per person covered per year using Carbamates for indoor residual spraying (IRS) in the rural area, excluding the costs of project management and monitoring and surveillance was $3.48 and in the peri-urban area, $2.16. The financial costs per person covered in the rural area and peri-urban area per year were $3.86 and $2.41, respectively. The economic costs per person covered were respectively increased by 39% and 31% when project management and monitoring and surveillance were included. The main driving forces behind the costs of delivering RHS are twofold: the population covered and insecticide used. Computed economic and financial costs are presented for all four insecticide families available for use in RHS.
CONCLUSIONS: The results from both these initiatives, especially the rural area, should be interpreted as conservative cost estimates as they exclude the additional health gains that the newly introduced programmes have had on malaria rates in the neighbouring areas of South Africa and Swaziland. Both these initiatives show that introducing an IRS programme can deliver a reduction in malaria-related suffering providing financial support, political will, collaborative management and training and community involvement are in place.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14728616     DOI: 10.1046/j.1365-3156.2003.01150.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  34 in total

1.  Prevalence of malaria among patients attending public health facilities in Maputo City, Mozambique.

Authors:  Alexandre Macedo de Oliveira; Rosalia Mutemba; Juliette Morgan; Elizabeth Streat; Jacquelin Roberts; Manoj Menon; Samuel Mabunda
Journal:  Am J Trop Med Hyg       Date:  2011-12       Impact factor: 2.345

2.  Climate influences on the cost-effectiveness of vector-based interventions against malaria in elimination scenarios.

Authors:  Paul E Parham; Dyfrig A Hughes
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-04-05       Impact factor: 6.237

3.  The importance of age dependent mortality and the extrinsic incubation period in models of mosquito-borne disease transmission and control.

Authors:  Steve E Bellan
Journal:  PLoS One       Date:  2010-04-13       Impact factor: 3.240

4.  The cost-effectiveness of intermittent preventive treatment for malaria in infants in Sub-Saharan Africa.

Authors:  Lesong Conteh; Elisa Sicuri; Fatuma Manzi; Guy Hutton; Benson Obonyo; Fabrizio Tediosi; Prosper Biao; Paul Masika; Fred Matovu; Peter Otieno; Roly D Gosling; Mary Hamel; Frank O Odhiambo; Martin P Grobusch; Peter G Kremsner; Daniel Chandramohan; John J Aponte; Andrea Egan; David Schellenberg; Eusebio Macete; Laurence Slutsker; Robert D Newman; Pedro Alonso; Clara Menéndez; Marcel Tanner
Journal:  PLoS One       Date:  2010-06-15       Impact factor: 3.240

5.  Cost effectiveness of seasonal intermittent preventive treatment using amodiaquine & artesunate or sulphadoxine-pyrimethamine in Ghanaian children.

Authors:  Lesong Conteh; Edith Patouillard; Margaret Kweku; Rosa Legood; Brian Greenwood; Daniel Chandramohan
Journal:  PLoS One       Date:  2010-08-17       Impact factor: 3.240

6.  Individual- and Household-Level Risk Factors Associated with Malaria in Mutasa District, Zimbabwe: A Serial Cross-Sectional Study.

Authors:  Mufaro Kanyangarara; Edmore Mamini; Sungano Mharakurwa; Shungu Munyati; Lovemore Gwanzura; Tamaki Kobayashi; Timothy Shields; Luke C Mullany; Susan Mutambu; Peter R Mason; Frank C Curriero; William J Moss
Journal:  Am J Trop Med Hyg       Date:  2016-04-25       Impact factor: 2.345

7.  Cost-Effectiveness of Indoor Residual Spraying of Households with Insecticide for Malaria Prevention and Control in Tanzania.

Authors:  Rachel Stelmach; Rajeev Colaço; Shabbir Lalji; Deborah McFarland; Richard Reithinger
Journal:  Am J Trop Med Hyg       Date:  2018-07-12       Impact factor: 2.345

8.  Seven years of regional malaria control collaboration--Mozambique, South Africa, and Swaziland.

Authors:  Brian L Sharp; Immo Kleinschmidt; Elisabeth Streat; Rajendra Maharaj; Karen I Barnes; David N Durrheim; Frances C Ridl; Natasha Morris; Ishen Seocharan; Simon Kunene; Jacobus J P LA Grange; Jotham D Mthembu; Francois Maartens; Carrin L Martin; Avertino Barreto
Journal:  Am J Trop Med Hyg       Date:  2007-01       Impact factor: 2.345

9.  What drives community adherence to indoor residual spraying (IRS) against malaria in Manhiça district, rural Mozambique: a qualitative study.

Authors:  Khátia Munguambe; Robert Pool; Catherine Montgomery; Carlos Bavo; Ariel Nhacolo; Lina Fiosse; Charfudin Sacoor; Delino Nhalungo; Samuel Mabunda; Eusébio Macete; Pedro Alonso
Journal:  Malar J       Date:  2011-11-23       Impact factor: 2.979

10.  Factors influencing the effectiveness of malaria control in Bioko Island, equatorial Guinea.

Authors:  Immo Kleinschmidt; Miguel Torrez; Chris Schwabe; Luis Benavente; Ishen Seocharan; David Jituboh; Gloria Nseng; Brian Sharp
Journal:  Am J Trop Med Hyg       Date:  2007-06       Impact factor: 2.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.